Functional Duality of Chondrocyte Hypertrophy and Biomedical Application Trends in Osteoarthritis
Open Access
- 26 July 2021
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (8) , 1139
Abstract
Chondrocyte hypertrophy is one of the key indicators in the progression of osteoarthritis (OA). However, compared with other OA indications, such as cartilage collapse, sclerosis, inflammation, and protease activation, the mechanisms by which chondrocyte hypertrophy contributes to OA remain elusive. As the pathological processes in the OA cartilage microenvironment, such as the alterations in the extracellular matrix, are initiated and dictated by the physiological state of the chondrocytes, in-depth knowledge of chondrocyte hypertrophy is necessary to enhance our understanding of the disease pathology and develop therapeutic agents. Chondrocyte hypertrophy is a factor that induces OA progression; it is also a crucial factor in the endochondral ossification. This review elaborates on this dual functionality of chondrocyte hypertrophy in OA progression and endochondral ossification through a description of the characteristics of various genes and signaling, their mechanism, and their distinguishable physiological effects. Chondrocyte hypertrophy in OA progression leads to a decrease in chondrogenic genes and destruction of cartilage tissue. However, in endochondral ossification, it represents an intermediate stage at the process of differentiation of chondrocytes into osteogenic cells. In addition, this review describes the current therapeutic strategies and their mechanisms, involving genes, proteins, cytokines, small molecules, three-dimensional environments, or exosomes, against the OA induced by chondrocyte hypertrophy. Finally, this review proposes that the contrasting roles of chondrocyte hypertrophy are essential for both OA progression and endochondral ossification, and that this cellular process may be targeted to develop OA therapeutics.Keywords
Funding Information
- the Dongguk University Research Fund of 2018 (the Dongguk University Research Fund of 2018)
- Ministry of Science and ICT, South Korea (NRF-2019R1A2B5B03069690, NRF-2019M3A9H1032376)
- Ministry of Education (NRF-2020R1I1A1A01074331)
This publication has 181 references indexed in Scilit:
- Biomaterials-Based Modulation of the Immune SystemBioMed Research International, 2013
- The Collagen FamilyCold Spring Harbor Perspectives in Biology, 2010
- Reconstitution of Marrow-Derived Extracellular Matrix Ex Vivo: A Robust Culture System for Expanding Large-Scale Highly Functional Human Mesenchymal Stem CellsStem Cells and Development, 2010
- Treatment of articular cartilage lesions of the kneeInternational Orthopaedics, 2010
- Matrix metalloproteinase 13–deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte developmentArthritis & Rheumatism, 2009
- Transglutaminase 2 is a marker of chondrocyte hypertrophy and osteoarthritis severity in the Hartley guinea pig model of knee OAOsteoarthritis and Cartilage, 2009
- Hydrogels as extracellular matrix mimics for 3D cell cultureBiotechnology and Bioengineering, 2009
- Chondrogenic Differentiation of Adipose-Derived Adult Stem Cells by a Porous Scaffold Derived from Native Articular Cartilage Extracellular MatrixTissue Engineering Part A, 2008
- HDAC4 Promotes Growth of Colon Cancer Cells via Repression of p21Molecular Biology of the Cell, 2008
- Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNature Cell Biology, 2007